Research

Parabolic Drugs adds 15 percent capacity to its Cephalosporin facility

Parabolic Drugs Ltd., a vertically integrated API manufacturer and exporter in India, today announced the commissioning of eighth manufacturing plant at its European GMP Accredited Derabassi facility – fully dedicated for the manufacturing of latest generation Cephalosporin, both in Oral and Sterile forms. Highlights of the new Manufacturing Plant

dIgitalhealth

Follow and connect with us on Facebook, Twitter, LinkedIn, Elets video

Eletsonline News

Follow us on


Most Popular

SUBSCRIBE OUR NEWSLETTER
200000+ Subscribers read it every day.
Subscribe Newsletter
To Top